A5039928844- Psoriasis: Treatment and Pathogenesis
- Dermatology and Skin Diseases
- Autoimmune Bullous Skin Diseases
- Hidradenitis Suppurativa and Treatments
- Dermatological and COVID-19 studies
- Colorectal and Anal Carcinomas
- Chemotherapy-related skin toxicity
- SARS-CoV-2 and COVID-19 Research
- Urticaria and Related Conditions
- Drug-Induced Adverse Reactions
- Cutaneous Melanoma Detection and Management
- Cutaneous lymphoproliferative disorders research
- Nail Diseases and Treatments
- Nonmelanoma Skin Cancer Studies
- Microscopic Colitis
- Acne and Rosacea Treatments and Effects
- Skin Diseases and Diabetes
- Herpesvirus Infections and Treatments
- Autoimmune and Inflammatory Disorders
- Asthma and respiratory diseases
- Contact Dermatitis and Allergies
- Artificial Intelligence in Healthcare and Education
- Oral Health Pathology and Treatment
- Skin and Cellular Biology Research
- melanin and skin pigmentation
University of Naples Federico II
2018-2025
Federico II University Hospital
2021-2022
Background: The treatment of hidradenitis suppurativa (HS) has always been a real challenge for dermatologists; to date, adalimumab the only biologic drug approved HS is adalimumab, an anti-tumor necrosis factor (TNF)-α drug, approval this dates 2015, data provided by life show effectiveness rate about 60% percent. Recently (31 October 2023) FDA approves secukinumab moderate-severe HS. and management very challenging as available treatments are limited variable outcomes. Methods: We...
The COVID 19 vaccination campaign has been underway for about a year now, and there are now many skin reactions associated with the administration of these vaccines in literature. In view forthcoming third dose, we believe it is important to report our experience.
Abstract Background Hidradenitis suppurativa (HS), an inflammatory-based dermatological condition often associated with obesity, poses significant challenges in management. The very low-calorie ketogenic diet (VLCKD) has shown efficacy addressing related metabolic disorders, and reducing chronic inflammation. However, its effects on HS remain underexplored. In this prospective pilot study, we aimed to investigate the impact of a 28-day active phase VLCKD sample treatment-naive women excess...
Background: It is now recognized that psoriasis plays a key role in the development of several comorbidities, such as cardiovascular disease, and metabolic syndrome. Some authors have hypothesized patients with may an increased risk developing certain types cancer. The efficacy safety biologic drugs are well-documented clinical trials real-life studies. However, there limited evidence on use treatments cancer psoriasis, this therapeutic class pre-existing or concomitant malignancy still...
The management of patients affected by moderate-to-severe psoriasis may be challenging, in particular with serious infectious diseases [tuberculosis (TB), hepatitis B and C, HIV, COVID-19]. Indeed, these infections should ruled out before starting during systemic treatment for psoriasis. Currently, four conventional drugs (methotrexate, dimethyl fumarate, acitretin, cyclosporine), classes biologics (anti-tumour necrosis factor alpha, anti-interleukin (IL)12/23, anti-IL-17s, anti-IL-23], two...
Hidradenitis suppurativa (HS) is a chronic, inflammatory, and debilitating skin disease, which usually occurs after puberty with painful, deep-seated, inflammatory lesions in the apocrine gland-bearing areas of body.1